Clinical trial
Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
NCT01774604 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- January 31, 2013
- Completion date
- December 31, 2014
- Enrollment
- 449 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
post-ercp acute pancreatitis